Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Prolonged QTc interval; and sometimes findings: Ventricular fibrillation, Aborted sudden cardiac death, Syncope, and Sudden cardiac death and others. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 4 | Ventricular fibrillation, Aborted sudden cardiac death, Sudden cardiac death |
CACNA1C encodes calcium voltage-gated channel subunit alpha1 C (2,221 aa). Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents. Highest expression in Colon Sigmoid (44.5 TPM) and Uterus (33.6 TPM).
Long QT syndrome 8 is associated with mutations in the CACNA1C gene on chromosome 12.
The CACNA1C protein participates in LTCC multimer transports Ca2+ from extracellular region to cytosol pathway.
CACNA1C is classified as a druggable target (Druggable Genome and Ion Channel categories) with score 0.4.
CACNA1C-related disorders should be considered in individuals with any of the following clinical and electrocardiographic findings and family history.
Clinical findings
Cardiovascular malformations such as ventricular septal defect, tetralogy of Fallot, or hypertrophic cardiomyopathy
Unilateral or bilateral cutaneous syndactyly variably involving fingers two (index), three (middle), four (ring), and five (little) and bilateral cutaneous syndactyly of toes two and three
No approved treatments are currently available for long QT syndrome 8. The disease remains an area of unmet medical need.
No specific clinical practice guidelines for CACNA1C-related disorders have been published; therefore, the general recommendations for the treatment of the specific disorder – long QT syndrome, Brugada syndrome, short QT syndrome – should apply, independent of the specific genetic cause .
To establish the extent of disease and needs in an individual diagnosed with a CACNA1C-related disorder, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 6. CACNA1C-Related Disorder: Recommended Surveillance
System/Concern |
|---|
No clinical trials have been registered for long QT syndrome 8.
5 publications have been identified in PubMed for long QT syndrome 8. Research spans Case Report / Case Series (40%), Epidemiology / Natural History (40%), and Clinical Trial Publication (20%).
Fanucci V (2025). [PMID: 40615216](https://pubmed.ncbi.nlm.nih.gov/40615216/). *JACC Case Rep*. [Case Report / Case Series]
Tadros R (2025). [PMID: 40185575](https://pubmed.ncbi.nlm.nih.gov/40185575/). *JACC Case Rep*. [Case Report / Case Series]
Yu L (2025). [PMID: 40526200](https://pubmed.ncbi.nlm.nih.gov/40526200/). *J Cardiovasc Transl Res*. [Clinical Trial Publication]
Timothy KW (2024). [PMID: 39580446](https://pubmed.ncbi.nlm.nih.gov/39580446/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Timothy KW (2024). [PMID: 38826393](https://pubmed.ncbi.nlm.nih.gov/38826393/). *medRxiv*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
Online Mendelian Inheritance in Man
Brain and nerves |
1 |
Intellectual disability |
Blood and immune system | 1 | Immunodeficiency |
The first CACNA1C-related disorder was referred to as Timothy syndrome , a condition with very high mortality with only a few individuals who reached reproductive age. Timothy syndrome consisted of the combination of prolonged QT interval, autism, and congenital heart defect with syndactyly of the fingers and toes; all these individuals had the same pathogenic variant, while a similar phenotype but without syndactyly was subsequently identified in association with comparable but distinct pathogenic variants . With the increased availability of molecular genetic testing, a wider spectrum of pathogenic variants and clinical findings associated with CACNA1C-related disorders have been recognized. Because CACNA1C is expressed at high levels both in the heart and in the central nervous system, pathogenic variants in CACNA1C can be associated with cardiac and/or neurologic manifestations. Review of the literature specifically focusing on the neurologic involvement in individuals with pathogenic variants in CACNA1C showed that intellectual disability is the most frequent phenotype (89%), followed by hypotonia (55.5%) ataxia (52%), seizures (37.9%), and autism (29%). Therefore, the clinical manifestations include a spectrum of nonsyndromic and syndromic phenotypes, which generally correlate with the impact of the pathogenic variant on calcium current (see and ): • Classic Timothy syndrome (prolonged QT interval, autism, and congenital heart defect) with or without syndactyly • CACNA1C-related neurodevelopmental disorder, in which the features tend to favor one or more of the following: developmental delay/ intellectual disability, hypotonia, epilepsy, and/or ataxia Note: For this phenotype, gain-of-function, neutral effect, and loss-of-function pathogenic variants have all been reported in affected individuals . • Nonsyndromic long QT syndrome (rate-corrected QT [QTc] interval 480 ms) • Short QT syndrome (QTc 350 ms), with risk of sudden death • Brugada syndrome (ST segment elevation in right precordial leads [V1-V2]) with short QT interval The clinical phenotype associated with large deletions/duplications is less defined, as few individuals with this phenotype have been reported . Table 2. CACNA1C-Related Disorders: Frequency of Select Features by Type of Pathogenic Variant
Variant Type | Feature | Frequency |
|---|---|---|
Nearly all | Common | Infrequent Gain-of- function pathogenic |
variants | Cardiac | QTc prolongation |
Cardiovascular malformations | Neurologic | Seizures |
Other | Typical craniofacial features | Cutaneous syndactyly |
variants1 | Cardiac | Short QT syndrome |
Sudden death | Neurologic |
Source: GeneReviews — "CACNA1C-Related Disorders"
Pathogenic variants that induce a gain of function at the cellular level (i.e., increased calcium current) are more likely to lead to:
The following electrophysiologic findings:
Long QTc
Bradycardia
2:1 AV block
Macroscopic T-wave alternans
Tacchyarrythmia/ sudden death
Congenital heart defects
Cutaneous syndactyly
Typical facial features
Developmental delay/ intellectual disability
Autism spectrum disorder
Seizures
Recurrent infections
Note: All reported CACNA1C pathogenic variants associated with QT prolongation (with or without syndromic features) occur in the intracellular portion of the protein. Pathogenic variants that cause a loss of function at the cellular level (i.e., reduced calcium current) are more likely to lead to:
Short QT syndrome
Brugada syndrome
Sudden death
Source: GeneReviews — "CACNA1C-Related Disorders"
The penetrance of pathogenic variants associated with typical Timothy syndrome is 100% . Nonsyndromic forms of CACNA1C-related disorders have lower penetrance that can be estimated in the range of 60%-80% on the basis of published literature .
Source: GeneReviews — "CACNA1C-Related Disorders"
Isolated neurologic manifestations, including:
Mild intellectual disability
Apraxia (constructional, dressing, and orobuccal)
Hypotonia
Poor balance or coordination
Autism spectrum disorder
Epilepsy, including generalized and/or focal seizures
Nonspecific dysmorphic facial features (See .)
Source: GeneReviews — "CACNA1C-Related Disorders"
Genetic Disorders in the Differential Diagnosis of CACNA1C-Related Cardiac Arrythmias Long QT syndrome (LQTS). Ten genes (including CACNA1C) are known to be associated with LQTS – of these, KCNH2, KCNQ1, and SCN5A are the most common (see ClinGen Long QT Syndrome Gene Curation Expert Panel) . Molecular genetic testing identifies a genetic cause in ~80% of individuals with LQTS, most often in genes associated with autosomal dominant LQTS.
Source: GeneReviews — "CACNA1C-Related Disorders"
Genetic testing for CACNA1C is available. Testing is considered confirmatory for diagnosis.
Table 4.
CACNA1C-Related Disorder: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| • Eval w/pediatric cardiologist incl EKG echocardiogram
24-hour Holter monitoring is relevant for initial clinical assessment of persons w/Brugada syndrome.
| Contrast echocardiogram, cardiac MR, ventriculography could be indicated if standard transthoracic echocardiogram is unable to conclusively exclude congenital defects.
| Physical exam for cutaneous syndactyly of hands feet | Consider consultation w/orthopedist.
Gastrointestinal/
| Gastroenterology/ nutrition/ feeding team eval | • To incl eval of aspiration risk nutritional status
Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk.
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
Neurobehavioral/
Source: GeneReviews — "CACNA1C-Related Disorders"
The following should be avoided:
All drugs reported to prolong QT interval (See CredibleMeds®.)
Drugs and dietary practices that could lead to hypoglycemia
Source: GeneReviews — "CACNA1C-Related Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "CACNA1C-Related Disorders"
View trials for long QT syndrome 8
Frequency |
|---|
Cardiac | Follow-up evals w/cardiologist incl EKG, Holter, echocardiogram | Every 6-12 mos Evals of persons w/pacemaker or ICD |
Musculoskeletal | Physical medicine, OT/PT assessment of mobility, self-help skills | At each visit Development |
Psychiatric | Behavioral assessment for ASD | Mandatory at first visit, followed by personalized follow up as needed |
Neurologic | Monitor those w/seizures as clinically indicated. | Every 6-12 mos Assess for new manifestations such as seizures, changes in tone, movement disorders. |
Source: GeneReviews — "CACNA1C-Related Disorders"
Phenotype severity distribution: 1 always present feature.
Seizures |
AI-curated news mentioning long QT syndrome 8
Updated Jul 17, 2026
A study published in the Spanish National Registry provides insights into clinical outcomes and therapy for pediatric long QT syndrome. This research highlights the need for improved management strategies in affected children.